[HTML][HTML] Assessment of the Impact of Carvedilol Administered Together with Dexrazoxan and Doxorubicin on Liver Structure and Function, Iron Metabolism, and …

J Szponar, A Gorska, M Ostrowska-Lesko… - International Journal of …, 2024 - mdpi.com
Late cardiotoxicity is a formidable challenge in anthracycline-based anticancer treatments.
Previous research hypothesized that co-administration of carvedilol (CVD) and dexrazoxane …